Resuscitation of the Helicobacter pylori Coccoid Forms by Resuscitation Promoter Factor Obtained from Micrococcus

Didem Aktas1, Melahat Bagirova2, Adil M Allahverdiyev1

  • 1Faculty of Chemical and Metallurgical Engineering Department of Bioengineering, Yildiz Technical University, Davutpasa Campus, Istanbul, Turkey.

Insights

Resuscitation promoter factor (RPF) from Micrococcus luteus can revert antibiotic-induced Helicobacter pylori coccoid forms back to spiral shapes. This finding may enhance antibiotic efficacy against H. pylori infections.

Area of Science:

  • Microbiology
  • Bacterial Pathogenesis
  • Drug Discovery

Background:

  • Helicobacter pylori infection affects over 55% of the global population.
  • H. pylori adopts a coccoid form under antibiotic pressure, reducing treatment effectiveness.
  • Micrococcus luteus secretes resuscitation promoter factor (RPF) with known effects on viable but non-culturable bacteria.

Purpose of the Study:

  • To investigate the potential of RPF from M. luteus to induce morphological transformation of H. pylori coccoid forms back to spiral forms.
  • To assess if this transformation can increase H. pylori susceptibility to conventional antibiotic treatments.

Main Methods:

  • Induction of H. pylori coccoid forms using kanamycin, prolonged culture, and temperature variations.
  • Isolation of RPF-containing metabolites from M. luteus culture supernatants.
  • Characterization of induced coccoid forms using microscopy, spectrophotometry, SEM, and flow cytometry.
  • Application of RPF-containing metabolites to H. pylori coccoids and assessment of morphological changes.

Main Results:

  • Kanamycin treatment was identified as the most effective method for inducing H. pylori coccoid forms.
  • RPF-containing metabolites from M. luteus demonstrated a significant resuscitation effect on kanamycin-induced H. pylori coccoids.
  • Morphological transformation from coccoid to spiral forms was observed for the first time using this method.

Conclusions:

  • RPF from M. luteus can effectively resuscitate H. pylori coccoid forms into their spiral state.
  • This novel approach holds promise for improving the efficacy of current antibiotic therapies against H. pylori infections.
  • Further research into RPF-mediated resuscitation could lead to new strategies for combating H. pylori.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
889
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.0K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
963